04/14/2025
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
7:57 AM | Verve Therapeutics (Filer)
| Form POS AM | |
02/27/2025
7:16 AM | Verve Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
6:45 AM | Verve Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:24 AM | Verve Therapeutics (Filer)
| Form POSASR | |
02/27/2025
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
6:53 AM | STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/10/2025
8:24 PM | ARK Investment Management LLC (Filed by)
Verve Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/10/2025
8:00 AM | Ashe Andrew D. (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Nickerson Joan (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Kathiresan Sekar (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VERV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/10/2025
8:00 AM | Lister Troy (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Politi Jason (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
3:30 PM | Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
4:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
11/05/2024
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
6:30 AM | Verve Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
12:52 PM | VANGUARD GROUP INC (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
10/16/2024
12:06 PM | STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G | |
09/09/2024
3:36 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
08/08/2024
6:30 AM | Verve Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
6:30 AM | Kathiresan Sekar (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:47 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
6:44 AM | Verve Therapeutics (Filer)
| Form 8-K/A | |
06/28/2024
6:45 AM | MacLean Michael F (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:45 AM | COATS LONNEL (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:45 AM | Morrison Jodie Pope (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:45 AM | Tatsis Ourania (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:45 AM | Cumbo Alexander (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:45 AM | ADELMAN BURT A (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:45 AM | Mikhail Sheila (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:45 AM | Verve Therapeutics (Issuer)
Yeshwant Krishna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:30 AM | Morrison Jodie Pope (Reporting)
Verve Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/28/2024
6:30 AM | Tatsis Ourania (Reporting)
Verve Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/28/2024
6:30 AM | Politi Jason (Reporting)
Verve Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
3:42 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G | |
06/25/2024
4:05 PM | Lister Troy (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad) Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you…
To partner with Elon on what he believes will be the biggest AI project of the century…
Starting with as little as $500. Click here to see how you could take a stake in Elon’s private company… |
05/31/2024
6:14 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
4:30 PM | Ashe Andrew D. (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:30 AM | Verve Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
6:56 AM | Verve Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
6:56 AM | Verve Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
6:59 AM | Verve Therapeutics (Filer)
| Form ARS | |
04/26/2024
6:59 AM | Verve Therapeutics (Filer)
| Form ARS | |
04/26/2024
6:30 AM | Verve Therapeutics (Filer)
| Form DEF 14A | |
